GL1X · GenesisL1 explorer

Research workbench

Pandda analysis group deposition of computational designs of SARS-cov- 2 main protease covalent inhibitors -- crystal structure of SARS-cov- 2 main protease in complex with lon-wei-ADC59DF6-2 (mpro-X3110)

Analyse Pandda analysis group deposition of computational designs of SARS-cov- 2 main… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5RL0
Type
protein
Length
304 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
VEG
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30425% helix, 29% strandP0DTD1

Ligands and binding sites

  • VEG · ethyl N-[(2R)-2-[(4-tert-butylphenyl)(propanoyl)amino]-2-(pyridin-3-yl)acetyl]-beta-alaninate · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12510.570.7829VEG
2860.490.8220DMS
31580.450.7529empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5RL0 · PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.